Jun 27 2025 This Week in Cardiology - podcast episode cover

Jun 27 2025 This Week in Cardiology

Jun 27, 202529 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Summary

This week's cardiology update covers the FDA's approval of a new triple-drug polypill for hypertension, alongside a shift in opinion on its practicality. The episode provides a critical deep dive into the evidence (or lack thereof) supporting invasive pulmonary embolism therapies, exploring the factors driving their popularity despite limited data. Finally, it analyzes long-term trends in heart disease mortality, noting a decline in ischemic deaths but a rise in other causes, and briefly highlights exciting progress in diabetes care.

Episode description

FDA approves triple-drug polypill, a change of opinion, a deep dive into invasive pulmonary embolism therapies, heart disease trends, and diabetes care is on fire are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I FDA News in HTN

II Invasive PE Therapy

III Heart Disease Trends

IV Diabetes Coverage

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

For the best experience, listen in Metacast app for iOS or Android